You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MET inhibitor

Showing 1 - 25 of 9,446
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Solid Tumor Trial in Bengbu (SPH 3348)

Recruiting
  • Solid Tumor
  • SPH 3348
  • Bengbu, Anhui, China
    The First Affliated Hospital of Bengbu Medical College
Jul 25, 2022

Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

Completed
Has Results
  • Malignant Non-small Cell Neoplasm of Lung Stage IV
  • Capmatinib (INC280)
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 11, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available Trial

Completed
Has Results
  • Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available
  • Houston, Texas
    M.D. Anderson Cancer Center
Aug 22, 2022

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor Trial in Bruxelles, Edegem, Rotterdam (DO-2)

Recruiting
  • Adult Solid Tumor
  • +2 more
  • Bruxelles, Belgium
  • +2 more
Mar 1, 2023

Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

Completed
  • Sarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Tumor, Solid Tumors Trial in Camperdown, Liverpool (HS-10241)

Completed
  • Neoplasm
  • Solid Tumors
  • Camperdown, New South Wales, Australia
  • +1 more
Jul 18, 2022

Hepatic Impairment Trial in Miami, Orlando (Tepotinib)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +1 more
Aug 22, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

Solid Tumors Trial in Kashiwa, Shizuoka (MSC2156119J)

Completed
Has Results
  • Solid Tumors
  • Kashiwa, Japan
  • +1 more
Jul 23, 2020

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
Has Results
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • Orange, California
  • +28 more
Feb 15, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Feb 4, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Polycystic Ovary Syndrome, Obesity Trial in Baton Rouge (Exenatide once weekly (EQW ), Dapagliflozin (DAPA), EQW plus DAPA)

Completed
Has Results
  • Polycystic Ovary Syndrome
  • Obesity
  • Exenatide once weekly (EQW )
  • +4 more
  • Baton Rouge, Louisiana
    Woman's Hospital
Jan 9, 2021

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021

Solid Tumor, C-Met Mutation-Related Tumors Trial in Shanghai (GST-HG161)

Unknown status
  • Solid Tumor
  • C-Met Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai Oriental Hospital
Jan 10, 2020

Glioma Trial in Beijing (PLB1001)

Completed
  • Glioma
  • Beijing, Beijing, China
    Beijing Shijitan Hospital,CMU
Mar 2, 2020

NSCLC Trial in Guangzhou (PLB1001)

Completed
  • Non-Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Nov 20, 2019